Figure 3. Sensitivity analysis: Vaccine efficacy. Effect of a change in Human papillomavirus (HPV) vaccine efficacy on the cost effectiveness of vaccination compared with current practice under varying assumptions of vaccine immunity. The triangles represent a vaccine which provides lifetime immunity to high-risk types of HPV. The circles represent a vaccine which requires booster shots every 10 years to remain effective (base-case assumption). The hatches represent a vaccine that requires booster shots every 5 years to remain effective. The dashed line indicates the $50,000 per quality-adjusted life year cost-effectiveness threshold. The base-case value of 75% efficacy is indicated by the arrow.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.